Martínez EV, Ramos GA, Valencia ÁM

Idioma: Español
Referencias bibliográficas: 15
Paginas: 104-109
Archivo PDF: 80.75 Kb.

RESUMEN

A la enfermedad de Bowen se le considera un cáncer in situ a partir del cual puede desarrollarse un carcinoma epidermoide, por lo que se requiere de un tratamiento oportuno y eficaz. Aunque en la actualidad existen otras alternativas, el de elección es el quirúrgico. En este artículo comunicamos un caso que se curó con cirugía.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Cox NH, Eedy DJ, Morton CA. Guidelines for management of BD: 2006; Rev BJD 2007; 156: 11-21.

2. Kao O, Naoko I, Yasuko F. Bowen’s disease on the sole associated with human papillomavirus type 31. Journal of Dermatology 2010; 37: 689-691.

3. Ted R, Mandy H, Marian G. Treatment of Bowen’s disease with topical 5% imiquimod cream: Retrospective study. Dermatol Surg 2007; 33: 427-432.

4. Jason H, Ashley D, Hobart W. Bowen’s disease: A four-year retrospective review of epidemiology and treatment at a University Center. Dermatol Surg 2008; 34: 878-883.

5. Ashley D, Hobart W. Variations in presentation of squamous cell carcinoma in situ (Bowen’s disease) in immunocompromized patients. J Am Acad Dermatol 2008; 59: 68-71.

6. Mitsuishi T, Nakatake M, Kaneko T. Evaluation of telomerase activity in non-genital Bowen’s disease. JEADV 2009; 23: 668-672.

7. Emmanuella G, Wolfram H, Gisela M. Multicentric Bowen disease in linear porokeratosis. EJD 2007; 17: 439-440.

8. Ozlen S, Mohamed S, Frederick M. Immunohistochemical staining of palisading basal cells in Bowen’s disease and basal involvement in actinic keratosis: Contrasting staining patterns suggest different cells of origin. AJ Dermatopathol 2008; 30: 123-126.

9. Gilberto M, Alvin L, Adrian L. Therapeutic options for Bowen’s disease. Australasian Journal of Dermatol 2007; 48: 1-10.

10. Ketty P, Tamara M, Maria C. Imiquimod 5% cream in the treatment of Bowen’s disease and invasive squamous cell carcinoma. J Am Acad Dermatol 2006; 55: 324-327.

11. Fabrizio F, Antonietta G, Anna Maria C. Pathologic changes after photodynamic therapy for basal cell carcinoma and Bowen disease. Arch Dermatol 2008; 144(2): 186-194.

12. Calzavara P, Venturini M, Sala R. Methylaminolaevulinate-based photodynamic therapy of Bowen’s disease and squamous cell carcinoma. BJD 2008; 159: 137-144.

13. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: Update. BJD 2008; 159: 1245-1266.

14. Jonathan B, Allan O. Amino evulinic acid photodynamic therapy for skin cancers. Dermatol Clin 2007; 25: 5-14.

15. Yung A, Johnson P. Topical photodynamic therapy for Bowen’s disease of the digit in epidermolysis bullosa. Br J Dermatol 2005; 153: 664-699.